Phibro Animal Health Co. (NASDAQ:PAHC) Director E Thomas Corcoran Buys 5,000 Shares of Stock

Phibro Animal Health Co. (NASDAQ:PAHC) Director E Thomas Corcoran purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was acquired at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the acquisition, the director now directly owns 25,000 shares of the company’s stock, valued at $500,500. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Phibro Animal Health Price Performance

PAHC stock opened at $19.46 on Friday. The company has a current ratio of 2.94, a quick ratio of 1.64 and a debt-to-equity ratio of 1.79. The company has a market capitalization of $788.13 million, a P/E ratio of 60.81, a PEG ratio of 1.66 and a beta of 0.52. The business has a 50 day simple moving average of $18.51 and a 200-day simple moving average of $16.28. Phibro Animal Health Co. has a twelve month low of $9.40 and a twelve month high of $22.31.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.47%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s payout ratio is currently 150.00%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. CWM LLC boosted its stake in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after buying an additional 1,035 shares during the period. Fidelis Capital Partners LLC purchased a new stake in Phibro Animal Health during the 1st quarter valued at approximately $46,000. China Universal Asset Management Co. Ltd. lifted its position in Phibro Animal Health by 65.0% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock worth $50,000 after acquiring an additional 1,531 shares during the period. Quest Partners LLC purchased a new position in shares of Phibro Animal Health in the 4th quarter valued at approximately $56,000. Finally, Summit Securities Group LLC acquired a new position in shares of Phibro Animal Health in the second quarter valued at approximately $83,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Barclays boosted their price target on shares of Phibro Animal Health from $10.00 to $13.00 and gave the company an “underweight” rating in a research report on Friday, May 10th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health has an average rating of “Hold” and a consensus target price of $13.25.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.